Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes

This study has been completed.
Information provided by:
Novartis Identifier:
First received: December 21, 2004
Last updated: May 1, 2012
Last verified: May 2012